{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:46:24Z","timestamp":1792691184685,"version":"4.5.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7,31]]},"DOI":"10.1097\/qad.0b013e32834917c6","type":"journal-article","created":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T03:25:04Z","timestamp":1306898704000},"page":"1497-1504","source":"Crossref","is-referenced-by-count":43,"title":["Elevated triglycerides and risk of myocardial infarction in HIV-positive persons"],"prefix":"10.1097","volume":"25","author":[{"given":"Signe W.","family":"Worm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Kamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Reiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Kirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafaa","family":"El-Sadr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Fux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Fontas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"D\u2019Arminio Monforte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"De Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Petoumenos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Friis-Mller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Mercie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens D.","family":"Lundgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Sabin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210130","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.2337\/dc07-2013","article-title":"Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.","volume":"31","author":"De Wit","year":"2008","journal-title":"Diabetes Care"},{"key":"R2-7-20210130","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1001\/archinte.165.10.1179","article-title":"Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study.","volume":"165","author":"Brown","year":"2005","journal-title":"Arch Intern Med"},{"key":"R4-7-20210130","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.23280","article-title":"Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications.","volume":"51","author":"Fabbrini","year":"2010","journal-title":"Hepatology"},{"key":"R5-7-20210130","first-page":"1045","article-title":"Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome.","volume":"74","author":"Grunfeld","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-7-20210130","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/135965350801300215","article-title":"Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial.","volume":"13","author":"Phillips","year":"2008","journal-title":"Antivir Ther"},{"key":"R7-7-20210130","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.ATV.0000152233.80082.9c","article-title":"Postprandial lipoprotein changes in patients taking antiretroviral therapy for HIV infection.","volume":"25","author":"Stein","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R8-7-20210130","doi-asserted-by":"crossref","first-page":"132","DOI":"10.5551\/jat.10.132","article-title":"Induction of atherosclerosis by human chylomicron remnants: a hypothesis.","volume":"10","author":"Wilhelm","year":"2003","journal-title":"J Atheroscler Thromb"},{"key":"R9-7-20210130","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1468-1293.2005.00328.x","article-title":"The effect of low-dose ritonavir monotherapy on fasting serum lipid concentrations.","volume":"6","author":"Shafran","year":"2005","journal-title":"HIV Med"},{"key":"R10-7-20210130","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1371\/journal.pmed.0010019","article-title":"Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1.","volume":"1","author":"van Leth","year":"2004","journal-title":"PLoS Med"},{"key":"R11-7-20210130","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1086\/381783","article-title":"Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles.","volume":"189","author":"Fontas","year":"2004","journal-title":"J Infect Dis"},{"key":"R12-7-20210130","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(08)60423-7","article-title":"Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multicohort collaboration.","volume":"371","author":"Sabin","year":"2008","journal-title":"Lancet"},{"key":"R13-7-20210130","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1086\/649897","article-title":"Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study.","volume":"201","author":"Worm","year":"2010","journal-title":"J Infect Dis"},{"key":"R14-7-20210130","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/jama.298.3.299","article-title":"Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women.","volume":"298","author":"Nordestgaard","year":"2007","journal-title":"JAMA"},{"key":"R15-7-20210130","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.298.3.309","article-title":"Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women.","volume":"298","author":"Bansal","year":"2007","journal-title":"JAMA"},{"key":"R16-7-20210130","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease.","volume":"302","author":"Di Angelantonio","year":"2009","journal-title":"JAMA"},{"key":"R17-7-20210130","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.106.637793","article-title":"Triglycerides and the risk of coronary heart disease: 10158 incident cases among 262525 participants in 29 western prospective studies.","volume":"115","author":"Sarwar","year":"2007","journal-title":"Circulation"},{"key":"R18-7-20210130","doi-asserted-by":"crossref","first-page":"377","DOI":"10.7326\/0003-4819-147-6-200709180-00007","article-title":"Changes in triglyceride levels and risk for coronary heart disease in young men.","volume":"147","author":"Tirosh","year":"2007","journal-title":"Ann Intern Med"},{"key":"R19-7-20210130","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0140-6736(08)61076-4","article-title":"Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study.","volume":"372","author":"McQueen","year":"2008","journal-title":"Lancet"},{"key":"R20-7-20210130","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1136\/bmj.307.6915.1318","article-title":"Nonfasting serum triglyceride concentration and mortality from coronary heart disease and any cause in middle aged Norwegian women.","volume":"307","author":"Stensvold","year":"1993","journal-title":"BMJ"},{"key":"R21-7-20210130","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1001\/archinte.163.9.1077","article-title":"Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease.","volume":"163","author":"Eberly","year":"2003","journal-title":"Arch Intern Med"},{"key":"R22-7-20210130","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0021-9150(98)00300-1","article-title":"Triglyceride as a risk factor for ischaemic heart disease in British men: effect of adjusting for measurement error.","volume":"143","author":"Egger","year":"1999","journal-title":"Atherosclerosis"},{"key":"R23-7-20210130","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1089\/aid.2005.21.757","article-title":"A randomized trial of the efficacy and safety of fenofibrate versus pravastatin in HIV-infected subjects with lipid abnormalities: AIDS Clinical Trials Group Study 5087.","volume":"21","author":"Aberg","year":"2005","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R24-7-20210130","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/QAI.0b013e31815bace2","article-title":"Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186.","volume":"47","author":"Gerber","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R26-7-20210130","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/ije\/dyi148","article-title":"The effect of measurement error in risk factors that change over time in cohort studies: do simple methods overcorrect for regression dilution.","volume":"34","author":"Frost","year":"2005","journal-title":"Int J Epidemiol"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QAD.0b013e32834917c6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:26:29Z","timestamp":1786044389000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-201107310-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,31]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32834917c6","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7,31]]}}}